Fanconi Anemia Mouse Genotype-specific Mitigation of Total Body Irradiation by GS-Nitroxide JP4-039.

Michael W. Epperly,Renee Fisher,Xichen Zhang,Wen Hou,Donna Shields,Peter Wipf,Hong Wang,Stephanie Thermozier,Joel S. Greenberger
DOI: https://doi.org/10.21873/invivo.11742
2019-01-01
In Vivo
Abstract:Background/Aim: Radiation mitigator, GS-nitroxide, JP4-039, was evaluated for mitigation of total body irradiation (TBI) in Fanconi anemia (FA) Fancd2(-/-)(129/Sv), Fancg(-/-) (B6), and Fanca(-/-) (129/Sv) mice. Materials and Methods: JP4-039 dissolved in 30% 2-hydroxypropyl-beta-cyclodextrin was injected intramuscularly 24 h after total body irradiation (9.25 Gy) into Fanca(-/-), Fancd2(-/-) and Fancg(-/-) mice. Irradiation survival curves were performed in vitro using bone marrow stromal cell lines derived from Fanca(-/-), Fancd2(-/-) and Fancg(-/-) mice. Results: FA mice demonstrate genotype specific differences in TBI mitigation by JP4-039. Radiation effects in derived bone marrow stromal cell lines in vitro were mitigated by drugs that block apoptosis, but not necroptosis or ferroptosis. Conclusion: FA mouse models are valuable for elucidating DNA repair pathways in cell and tissue responses to TBI, and the role of drugs that target distinct cell death pathways.
What problem does this paper attempt to address?